201 related articles for article (PubMed ID: 24762111)
1. Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study.
Ahmed AH; Cowley D; Wolley M; Gordon RD; Xu S; Taylor PJ; Stowasser M
J Clin Endocrinol Metab; 2014 Aug; 99(8):2745-53. PubMed ID: 24762111
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Seated With Recumbent Saline Suppression Testing for the Diagnosis of Primary Aldosteronism.
Stowasser M; Ahmed AH; Cowley D; Wolley M; Guo Z; McWhinney BC; Ungerer JP; Gordon RD
J Clin Endocrinol Metab; 2018 Nov; 103(11):4113-4124. PubMed ID: 30239841
[TBL] [Abstract][Full Text] [Related]
3. Exploration Of The Seated Saline Suppression Test For The Diagnosis Of Primary Aldosteronism In The Chinese Population.
Zhang D; Chen T; Tian H; Li Y; Mo D; Zhang T; Wang W; Zhang G; Liu Y; Tang L; Zhu Y; Yang L; Ren Y
Endocr Pract; 2020 Aug; 26(8):891-899. PubMed ID: 33471680
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of Primary Aldosteronism by Seated Saline Suppression Test-Variability Between Immunoassay and HPLC-MS/MS.
Thuzar M; Young K; Ahmed AH; Ward G; Wolley M; Guo Z; Gordon RD; McWhinney BC; Ungerer JP; Stowasser M
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31676899
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the saline infusion test and the fludrocortisone suppression test for the diagnosis of primary aldosteronism.
Willenberg HS; Vonend O; Schott M; Gao X; Blondin D; Saleh A; Rump LC; Scherbaum WA
Horm Metab Res; 2012 Jun; 44(7):527-32. PubMed ID: 22689209
[TBL] [Abstract][Full Text] [Related]
6. [The application of captopril challenge test in the diagnosis of primary aldosteronism].
Chen S; Zeng ZP; Song AL; Zhu L; Lu L; Tong AL; Shi C; Li HZ
Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):402-408. PubMed ID: 28592038
[No Abstract] [Full Text] [Related]
7. Comparison of confirmatory tests for the diagnosis of primary aldosteronism.
Mulatero P; Milan A; Fallo F; Regolisti G; Pizzolo F; Fardella C; Mosso L; Marafetti L; Veglio F; Maccario M
J Clin Endocrinol Metab; 2006 Jul; 91(7):2618-23. PubMed ID: 16670162
[TBL] [Abstract][Full Text] [Related]
8. Seated saline infusion test in predicting subtype diagnosis of primary aldosteronism.
Kaneko H; Umakoshi H; Ishihara Y; Sugawa T; Nanba K; Tsuiki M; Kusakabe T; Satoh-Asahara N; Yasoda A; Tagami T
Clin Endocrinol (Oxf); 2019 Dec; 91(6):737-742. PubMed ID: 31618467
[TBL] [Abstract][Full Text] [Related]
9. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
[TBL] [Abstract][Full Text] [Related]
10. Suppression of Aldosterone Secretion After Recumbent Saline Infusion Does Not Exclude Lateralized Primary Aldosteronism.
Cornu E; Steichen O; Nogueira-Silva L; Küpers E; Pagny JY; Grataloup C; Baron S; Zinzindohoue F; Plouin PF; Amar L
Hypertension; 2016 Oct; 68(4):989-94. PubMed ID: 27600182
[TBL] [Abstract][Full Text] [Related]
11. Seated Saline Suppression Test Is Comparable With Captopril Challenge Test for the Diagnosis of Primary Aldosteronism: A Prospective Study.
Liu B; Hu J; Song Y; He W; Cheng Q; Wang Z; Feng Z; Du Z; Xu Z; Yang J; Li Q; Yang S;
Endocr Pract; 2021 Apr; 27(4):326-333. PubMed ID: 33779561
[TBL] [Abstract][Full Text] [Related]
12. Re-evaluation of the fludrocortisone test: duration, NaCl supplementation and cut-off limits for aldosterone.
Westerdahl C; Bergenfelz A; Larsson J; Nerbrand C; Valdemarsson S; Wihl A; Isaksson A
Scand J Clin Lab Invest; 2009; 69(2):234-41. PubMed ID: 18951242
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone LC-MS/MS Assay-Specific Threshold Values in Screening and Confirmatory Testing for Primary Aldosteronism.
Guo Z; Poglitsch M; McWhinney BC; Ungerer JPJ; Ahmed AH; Gordon RD; Wolley M; Stowasser M
J Clin Endocrinol Metab; 2018 Nov; 103(11):3965-3973. PubMed ID: 30137438
[TBL] [Abstract][Full Text] [Related]
14. Saline suppression test parameters may predict bilateral subtypes of primary aldosteronism.
Hashimura H; Shen J; Fuller PJ; Chee NYN; Doery JCG; Chong W; Choy KW; Gwini S; Yang J
Clin Endocrinol (Oxf); 2018 Sep; 89(3):308-313. PubMed ID: 29873811
[TBL] [Abstract][Full Text] [Related]
15. Primary aldosteronism: inability to differentiate unilateral from bilateral adrenal lesions by various routine clinical and laboratory data and by peripheral plasma aldosterone.
Vetter H; Siebenschein R; Studer A; Witassek F; Furrer J; Glänzer K; Siegenthaler W; Vetter W
Acta Endocrinol (Copenh); 1978 Dec; 89(4):710-25. PubMed ID: 213920
[TBL] [Abstract][Full Text] [Related]
16. Should aldosterone suppression tests be conducted during a particular phase of the menstrual cycle, and, if so, which phase? Results of a preliminary study.
Ahmed AH; Gordon RD; Ward G; Wolley M; Kogovsek C; Stowasser M
Clin Endocrinol (Oxf); 2015 Sep; 83(3):303-7. PubMed ID: 25523596
[TBL] [Abstract][Full Text] [Related]
17. [Aldosterone/renin ratio in the diagnosis of primary aldosteronism].
Ríos MC; Izquierdo A; Sotelo M; Honnorat E; Rodríguez Cuimbra S; Catay E; Popescu BM
Medicina (B Aires); 2011; 71(6):525-30. PubMed ID: 22167725
[TBL] [Abstract][Full Text] [Related]
18. Can Screening and Confirmatory Testing in the Management of Patients with Primary Aldosteronism be Improved?
Stowasser M; Ahmed A; Guo Z; Wolley M; Ungerer J; McWhinney B; Poglitsch M; Gordon R
Horm Metab Res; 2017 Dec; 49(12):915-921. PubMed ID: 29132172
[TBL] [Abstract][Full Text] [Related]
19. Saline suppression to distinguish the primary aldosteronism subtype: a diagnostic study.
Hashimura H; Hu J; Kobayashi H; Gwini SM; Shen J; Chee NYN; Doery JCG; Chong W; Fuller PJ; Abe M; Li Q; Yang J
Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36651157
[TBL] [Abstract][Full Text] [Related]
20. Nocturnal, daytime, and postural changes of plasma aldosterone before and during dexamethasone in adenomatous and idiopathic aldosteronism.
Hoefnagels WH; Drayer JI; Smals AG; Benraad TJ; Kloppenborg PW
J Clin Endocrinol Metab; 1980 Dec; 51(6):1330-4. PubMed ID: 7440698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
